about
The blind men 'see' the elephant-the many faces of fatty liver diseaseROR nuclear receptors: structures, related diseases, and drug discoveryTime-resolved expression profiling of the nuclear receptor superfamily in human adipogenesis.The benzenesulfoamide T0901317 [N-(2,2,2-trifluoroethyl)-N-[4-[2,2,2-trifluoro-1-hydroxy-1-(trifluoromethyl)ethyl]phenyl]-benzenesulfonamide] is a novel retinoic acid receptor-related orphan receptor-alpha/gamma inverse agonist.Activation of xenobiotic receptors: driving into the nucleus.Positive and negative regulation of chicken anemia virus transcription.Drug resistance in brain diseases and the role of drug efflux transporters.Action of RORs and their ligands in (patho)physiology.Modulation of the growth hormone-insulin-like growth factor (GH-IGF) axis by pharmaceutical, nutraceutical and environmental xenobiotics: an emerging role for xenobiotic-metabolizing enzymes and the transcription factors regulating their expression.Stress- (and diet-) related regulation of hepatic nuclear receptors and its relevance for ABC-transporter functions.Cholesterol and 24S-hydroxycholesterol trafficking in Alzheimer's disease.Orphan nuclear receptors: therapeutic opportunities in skeletal muscle.Elevated insulin secretion from liver X receptor-activated pancreatic beta-cells involves increased de novo lipid synthesis and triacylglyceride turnoverIntrinsic disorder in nuclear hormone receptors.1,1-bis(3'-indolyl)-1-(p-substituted phenyl)methanes decrease mitochondrial membrane potential and induce apoptosis in endometrial and other cancer cell linesDynamics of nuclear receptor target gene regulation.Intrinsically disordered proteins and novel strategies for drug discovery.Role of polymer-drug conjugates in organ-specific delivery systems.Emerging roles of orphan nuclear receptors in regulation of innate immunity.The Isoxazole Ring and Its N-Oxide: A Privileged Core Structure in Neuropsychiatric Therapeutics.Dynamic nature of transcriptional regulation of nuclear receptor target genes in the context of chromatin organization.Activation of Nur77 by selected 1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes induces apoptosis through nuclear pathways.Crystal structure of (20S)-21-[4-(2-hy-droxy-propan-2-yl)-1H-1,2,3-triazol-4-yl]-20-(4-methyl-pent-yl)-5-pregnen-3β-ol with an unknown solvate.
P2860
Q24654991-D4458E7D-004A-4F67-AFB8-6FC0D306A2FDQ26861208-8F760949-BF54-4077-8C2A-F5649597C902Q30989922-D66E6C8E-AE22-4570-8309-3066A898E6B7Q33613397-A6594A83-E4DB-4293-812D-04FBD4BEFFBFQ33742134-1F379C6A-CD9E-4B81-A297-C6C77D8605E9Q33835347-23323010-B2C4-4EEA-AE18-5EBA47F87108Q33988704-940CBFB4-05C8-4E70-B89C-A4E7B55CDB42Q34287702-4EC4605D-425F-46C7-995F-681ED71997D3Q34526408-18479FF7-4EDE-4B7B-99E8-88A46320C544Q35828054-14601409-CC7A-4A65-A744-5213DDCE0A14Q36492343-3D22F375-691B-4FF5-8869-E7CEFA5B73B3Q36529528-2CA427C9-8BDB-4B75-B240-0DA38F49BD3BQ37210798-362697F1-11F2-4D0F-9903-0A53845DE8F0Q37238407-B427D4CA-08EE-471D-92D1-398E4CBA7DA0Q37263942-2A8A832A-E0C6-447C-A31F-75B757E91C72Q37772133-3398F97A-8E28-40D1-8E77-93BFE0A34642Q38007557-ED1B077E-E56F-49D2-9F68-D6CA02CDCF9CQ38365556-E8167156-0276-40F6-8BEB-37EE274BEEDEQ38971639-AB4E67B0-2089-48F0-A6E4-B148393ED989Q39157903-62890994-3EE3-46DD-81C0-0336CFBD3AF8Q39194197-84FEE109-A144-48D1-8FF7-7F6A344E9438Q40426627-0DC0C668-7635-4A75-8A0B-E355A1D3501FQ54947599-349CAFC2-9AD1-4C00-B47F-CD104218F996
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականին հրատարակուած գիտական յօդուած
@hyw
2003 թվականին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Orphan nuclear receptor modulators
@ast
Orphan nuclear receptor modulators
@en
Orphan nuclear receptor modulators
@nl
type
label
Orphan nuclear receptor modulators
@ast
Orphan nuclear receptor modulators
@en
Orphan nuclear receptor modulators
@nl
prefLabel
Orphan nuclear receptor modulators
@ast
Orphan nuclear receptor modulators
@en
Orphan nuclear receptor modulators
@nl
P356
P1476
Orphan nuclear receptor modulators
@en
P2093
Raju Mohan
Richard A Heyman
P304
P356
10.2174/1568026033451709
P407
P577
2003-01-01T00:00:00Z